Turning Off the ApoE4 Gene To Prevent Alzheimer’s ?!
Insights on myelin, CRISPR gene silencing, lipid metabolism, and prevention.

Key takeaways · TL;DR
Two breakthroughs from the March 2025 APOE and Lipid Biology conference: lipid droplet buildup in oligodendrocytes may be one of the earliest signs of APOE4 brain dysfunction, and a new CRISPR interference technique can silence APOE4 in neurons without editing DNA. Targeting GSK3-beta and Wnt signaling could restore healthy fat metabolism and protect myelin.
Definition
Gene silencing technique that blocks gene expression without editing DNA, being developed to turn off APOE4 in neurons.
Definition
Brain cell that produces the myelin insulation around nerve fibers, showing lipid droplet buildup in APOE4 carriers.
Hi friends,
In this episode, I break down two groundbreaking Alzheimer’s prevention discoveries—directly from the Alzheimer’s Association International Conference on APOE and Lipid Biology (March 2025).
These insights reveal how APOE4 disrupts brain metabolism decades before symptoms begin—and what researchers are doing to stop it.
You’ll discover:
How lipid droplet buildup in oligodendrocytes could be one of the earliest signs of brain dysfunction in ApoE4 carriers
A groundbreaking CRISPR interference technique that silences APOE4 in neurons—without editing your DNA
Why targeting GSK3-beta and Wnt signaling could help restore healthy fat metabolism and protect myelin
Why these findings matter now—for prevention, resilience, and smarter protocols


